Table 2.
Training | Validation | Testing | |
---|---|---|---|
Normal | 132,185 / 332 | 28,403 / 53 | 28,741 / 74 |
Primary tumor | 556,449 / 825 | 121,094 / 181 | 121,059 / 170 |
Training | Validation | Testing | |
---|---|---|---|
Normal | 132,185 / 332 | 28,403 / 53 | 28,741 / 74 |
Primary tumor | 556,449 / 825 | 121,094 / 181 | 121,059 / 170 |